RecruitingNot ApplicableNCT07331519

Integrating Smoking Cessation With Low-dose CT-screening for Lung Cancer

Integrating Smoking Cessation With Low-dose CT-screening for Lung Cancer - a Randomized Study


Sponsor

Oulu University Hospital

Enrollment

1,200 participants

Start Date

Feb 2, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The study investigates effectiveness of different smoking cessation methods and low-dose CT based lung cancer screening


Eligibility

Min Age: 50 YearsMax Age: 74 Years

Inclusion Criteria4

  • Able to provide written informed consent
  • Age between 50-74
  • Smoked ≥ 15 cigarettes/day for ≥ 25 years or smoked ≥ 10 cigarettes/day for ≥ 30 years and are active smokers (smoking during the last two weeks)
  • Access to a smartphone (iPhone or Android)

Exclusion Criteria6

  • Current or past melanoma, lung, renal or breast cancer
  • A chest CT examination less than one year before inclusion
  • Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial
  • No access to a smartphone (iPhone or Android)
  • Participant is unwilling or unable to comply with treatment and trial instructions
  • Any condition that study investigators consider an impediment to safe trial participation

Interventions

OTHERSmartphone application

Suunta smartphone application for smoking cessation

OTHERlow-dose computed tomography

Low-dose computed tomography based screening for lung cancer

OTHERWritten materials for smoking cessation

Written materials for smoking cessation


Locations(5)

Helsinki University Hospital

Helsinki, Finland

Oulu University Hospital

Oulu, Finland

Tampere University Hospital

Tampere, Finland

Turku University Hospital

Turku, Finland

Vaasa Central Hospital

Vaasa, Finland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07331519


Related Trials